Track the 중앙첨단소재 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 중앙첨단소재 has logged 60 public disclosures. Market capitalisation: €106.8bn. The latest transaction was reported on 26 March 2026 (Other). Among the most active insiders: 아틀라스팔천. Every trade is free.
60
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
20 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,233 of 29,057 companies
30.7
score / 100
Value
37
Quality
25
FCF yld2.1%
Earn yld-4.7%
EV/EBITDA·
ROE-3.6%
Gross mgn30%
Net mgn-28%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
중앙첨단소재 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el XKRX. Se centra en el desarrollo de materiales avanzados para aplicaciones médicas.